FindTrial
Sign In

BRANCH 1 Type of group

4 trials

Sponsors

AMGEN INC.,, NOVARTIS BIOSCIENSES PERU S.A.,, INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,, AGMT-AUSTRIA,

Unknown Phase

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Active, not recruitingPER-062-06
INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,
Updated: 2023-09-04
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation Alone in Patients With Aggressive B-cell Lymphoma: NHL-13
Active, not recruitingPER-107-06
AGMT-AUSTRIA,
Start: 2007-07-18Target: 10Updated: 2023-09-04
Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer (SPECTRUM)
Active, not recruitingPER-020-07
AMGEN INC.,
Start: 2007-03-30Target: 9Updated: 2023-09-04
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study
Active, not recruitingPER-043-07
NOVARTIS BIOSCIENSES PERU S.A.,
Target: 143Updated: 2023-09-04